University of Texas Medical Branch: Combination Therapy Protects Against Advanced Marburg Virus Disease
March 27, 2021
March 27, 2021
GALVESTON, Texas, March 27 (TNSJou) -- The University of Texas Medical Branch issued the following news release on March 26, 2021:
A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus. The study was published today in Nature Communications.
"Marburg is a highly virulent d . . .
A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus. The study was published today in Nature Communications.
"Marburg is a highly virulent d . . .